Dual checkpoint inhibitors (not disclosed)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dual checkpoint inhibitors (not disclosed), covering 2025-01-01 to 2025-01-01. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors [Phase 2]